1. Home
  2. SPOK vs TNYA Comparison

SPOK vs TNYA Comparison

Compare SPOK & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOK
  • TNYA
  • Stock Information
  • Founded
  • SPOK 2004
  • TNYA 2016
  • Country
  • SPOK United States
  • TNYA United States
  • Employees
  • SPOK N/A
  • TNYA N/A
  • Industry
  • SPOK Telecommunications Equipment
  • TNYA Medicinal Chemicals and Botanical Products
  • Sector
  • SPOK Telecommunications
  • TNYA Health Care
  • Exchange
  • SPOK Nasdaq
  • TNYA Nasdaq
  • Market Cap
  • SPOK 379.1M
  • TNYA 326.0M
  • IPO Year
  • SPOK 1992
  • TNYA 2021
  • Fundamental
  • Price
  • SPOK $16.20
  • TNYA $1.66
  • Analyst Decision
  • SPOK
  • TNYA Strong Buy
  • Analyst Count
  • SPOK 0
  • TNYA 5
  • Target Price
  • SPOK N/A
  • TNYA $8.60
  • AVG Volume (30 Days)
  • SPOK 109.4K
  • TNYA 4.6M
  • Earning Date
  • SPOK 10-29-2025
  • TNYA 11-06-2025
  • Dividend Yield
  • SPOK 7.73%
  • TNYA N/A
  • EPS Growth
  • SPOK 10.71
  • TNYA N/A
  • EPS
  • SPOK 0.83
  • TNYA N/A
  • Revenue
  • SPOK $140,742,000.00
  • TNYA N/A
  • Revenue This Year
  • SPOK $5.45
  • TNYA N/A
  • Revenue Next Year
  • SPOK $0.56
  • TNYA N/A
  • P/E Ratio
  • SPOK $19.49
  • TNYA N/A
  • Revenue Growth
  • SPOK 1.79
  • TNYA N/A
  • 52 Week Low
  • SPOK $13.55
  • TNYA $0.36
  • 52 Week High
  • SPOK $19.31
  • TNYA $4.01
  • Technical
  • Relative Strength Index (RSI)
  • SPOK 43.23
  • TNYA 49.55
  • Support Level
  • SPOK $15.59
  • TNYA $1.65
  • Resistance Level
  • SPOK $16.09
  • TNYA $2.02
  • Average True Range (ATR)
  • SPOK 0.31
  • TNYA 0.17
  • MACD
  • SPOK 0.09
  • TNYA -0.05
  • Stochastic Oscillator
  • SPOK 87.31
  • TNYA 4.29

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Share on Social Networks: